Aim: This study aimed to present the results of carotid artery stenting (CAS) in the treatment of patients with symptomatic and asymptomatic carotid artery stenosis (Cs).
Material and Method: Between September 2016 and June 2021, patients who underwent CAS in the interventional radiology department were reviewed, retrospectively. The demographic data of patients, comorbidities, carotid stenosis rates, and early and late complication rates after treatment were recorded from medical records. Acute stent thrombosis, stroke, and death in the first 30 days after CAS were considered early periprocedural complications. Doppler ultrasonography (USG) examinations were scanned at 6 months after the procedure and restenosis rates were investigated.
Results: There were a total of 113 patients; 31.2% female and 68.8% male. Symptomatic Cs was present in 62.8% (n=71) and asymptomatic Cs in 37.2% (n=42) of the patients. The technical success rate was determined as 98.2%. Micro-thromboembolism (n=4), pseudoaneurysm at the femoral insertion site (n=2), and acute stent thrombosis (n=1) were observed as early complications. Restenosis was detected 6 months after stenting in 1 patient (1.4%) with symptomatic Cs on Doppler USG. The mortality rate was 0.8% (n=1).
Conclusion: CAS is an effective and safe treatment method in symptomatic and asymptomatic patients with Cs.
NONE
NONE
NONE
NONE
Primary Language | English |
---|---|
Subjects | Health Care Administration |
Journal Section | Original Article |
Authors | |
Project Number | NONE |
Publication Date | January 17, 2022 |
Published in Issue | Year 2022 Volume: 5 Issue: 1 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.